Quarterly report [Sections 13 or 15(d)]

Stock-Based Compensation (Tables)

v3.25.1
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2025
Schedule of number of cash-settled RSUs granted

Three months ended

March 31, 2025

Awards Granted (000's)

Weighted
Average
GDFV

QVCGA cash-settled RSUs (1)

126,658

N/A

QVCGA stock-settled RSUs, mainly to our President and CEO (2)

16,219

$

0.28

(1) Grants mainly vest equally over three years.
(2) Grant to Mr. Rawlinson was made in connection with his employment agreement and vests equally over three years (see note 8).
Schedule of number and weighted average GDFV of QVC Group stock-settled RSUs granted to certain officers, employees and directors

Weighted

Weighted

Series A

Average

Series B

Average

(000's)

GDFV

(000's)

GDFV

Outstanding at January 1, 2025

 

8,760

$

2.35

296

$

5.01

Granted

 

16,219

$

0.28

$

Vested

 

(5,476)

$

3.02

(296)

$

5.01

Forfeited/Cancelled

 

(927)

$

1.40

$

Outstanding at March 31, 2025

 

18,576

$

0.39

$

 

Schedule of cash-settled RSUs and PSUs granted to certain officers and employees

QVCGA

QVCGA

Total QVCGA

RSUs

PSUs

RSUs & PSUs

(000's)

(000's)

(000's)

Outstanding at January 1, 2025

 

19,407

35,862

55,269

Granted

 

126,658

126,658

Vested

 

(6,502)

(933)

(7,435)

Forfeited/Cancelled

 

(540)

(19,016)

(19,556)

Outstanding at March 31, 2025

 

139,023

15,913

154,936

Common stock Series A  
Schedule of Share-Based payment arrangement, Activity

    

    

    

Weighted

    

Aggregate

 

average

intrinsic

Series A

remaining

value

(000's)

WAEP

life

(millions)

Options outstanding at January 1, 2025

 

19,231

$

7.09

Granted

 

$

Exercised

 

$

Forfeited/Cancelled

 

(2,646)

$

13.67

Options outstanding at March 31, 2025

 

16,585

$

6.04

 

1.9

years

$

Options exercisable at March 31, 2025

 

16,585

$

6.04

 

1.9

years

$

Common stock Series B  
Schedule of Share-Based payment arrangement, Activity

    

    

    

Weighted

    

Aggregate

 

average

intrinsic

Series B

remaining

value

(000's)

WAEP

life

(millions)

Options outstanding at January 1, 2025

 

407

$

12.95

Granted

 

$

Exercised

 

$

Forfeited/Cancelled

(360)

$

13.49

Options outstanding at March 31, 2025

 

47

$

8.76

 

0.9

years

$

Options exercisable at March 31, 2025

 

47

$

8.76

 

0.9

years

$